Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2003
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2205509C Microbicidal triazolyl derivatives
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082890A1 Diastereoselective process for preparing of beta-d and beta-l 2' , 3' -dideoxy nucleoside analogs
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082847A1 Benzofuran derivative
10/09/2003WO2003082846A1 Anomeric derivatives of monosaccharides
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003US20030191320 Process for the preparation of bis-benzazolyl compounds
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191314 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/09/2003US20030191311 Imidazole derivatives
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191176 Stable hydrate of a muscarinic receptor antagonist
10/09/2003US20030191171 Insecticidal and acaricidal agent
10/09/2003US20030191164 Propane-1,3-dione derivatives
10/09/2003US20030191163 Substituted cyclic amine metalloprotease inhibitors
10/09/2003US20030191158 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191132 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191129 Antitumor agents
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191113 For agriculture
10/09/2003US20030191112 Novel substituted piperidines
10/09/2003US20030191110 Anticholesterol agents; cardiovascular disorders
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
10/09/2003US20030191069 2-oxoquinoline compounds and pharmaceutical uses thereof
10/09/2003US20030190743 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
10/09/2003US20030190680 Photocleavable bioreactive agents
10/09/2003CA2480888A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003CA2480638A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003CA2480578A1 Anomeric derivatives of monosaccharides
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003CA2479453A1 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003CA2478918A1 Angiogenesis inhibitors
10/08/2003EP1349853A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
10/08/2003EP1349851A1 Compounds
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1171437B1 Pesticidal indazole or benzotriazole derivatives
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0929299B1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA(b)BENZOFURANS
10/08/2003EP0927170B1 Piperazino derivatives as neurokinin antagonists
10/08/2003EP0923556B1 An asymmetric conjugate addition reaction
10/08/2003CN1447807A Chromenone derivatives and their use for treating diseases in conjunction with 5-HT1A receptors and/or dopamine D2 receptors
10/08/2003CN1447806A 4-,5-,6-and 7-indole derivatives useful for treatment of CNS disorders
10/08/2003CN1447794A Novel compounds
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630594 Spiro-pyran compounds; use as pesticides and herbicides
10/07/2003US6630593 A process for preparing a 1-substituted 5-hydroxymethylimidazole of the formula: wherein R represents alkyl, hydroxyalkyl, allyl, or substituted or unsubstituted arylmethyl or diarylmethyl, comprising the step of reacting a
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630510 Substituted succinic acid metallo-β-lactamase inhibitors and their use in treating bacterial infections
10/07/2003US6630506 Useful as antianginal agents, and cardioprotective agents and for treating peripheral vascular disease including intermittent claudication
10/07/2003US6630505 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630496 Inhibitors of phospholipase enzymes
10/07/2003US6630495 Compound containing 2-pyridyl or its N-oxide
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630480 Methods of treating leukemia
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/02/2003WO2003080599A1 Stable hydrate of a muscarinic receptor antagonist
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080577A2 Amidoacetonitrile compounds
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003WO2003080076A1 Novel therapeutic use of riboside of 5-aminoimidazole-4- carboxamide (acadesine)
10/02/2003WO2003080055A1 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079975A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
10/02/2003WO2003079973A2 Mitotic kinesin inhibitors
10/02/2003WO2003024939A3 Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers
10/02/2003US20030187269 Novel process
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187267 Novel 1,2,3,4-tetrahydroisoquinoline, their preparation method and their use as fungicides
10/02/2003US20030187266 Non-nucleoside reverse transcriptase inhibitors
10/02/2003US20030187265 Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
10/02/2003US20030187264 Process for producing carbonyl hydrazones
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 694